Can Hip Dysplasia Be Cured? Treatment and Outlook

Hip dysplasia can often be resolved completely when caught early in infancy, and it can be managed effectively at later stages, but calling it “cured” depends heavily on when treatment begins and how severe the condition is. A baby treated with a harness in the first few months of life may grow a perfectly normal hip joint and never think about it again. An adult diagnosed in their thirties faces a more complex picture: joint-preservation surgery can delay or prevent arthritis for years, but the underlying anatomy may never be entirely normal. The word “cure” fits some scenarios better than others, and understanding why requires walking through how treatment works at each stage of life.

Why the Hip Goes Wrong

In a healthy hip, the ball at the top of the thighbone sits snugly inside a cup-shaped socket in the pelvis. In dysplasia, that socket is too shallow, too steep, or poorly oriented, so the ball doesn’t get the coverage it needs. The result is uneven pressure distribution across the cartilage. One study using computer modeling found that the peak contact pressure in dysplastic hips was roughly twice that of normal hips during standing, around 7.3 megapascals compared with 3.5 in controls.¹ Over years of walking, that chronic overload grinds down cartilage much faster than normal, setting the stage for early arthritis.

The causes are a mix of genetics and environment. Researchers have now identified multiple genes linked to developmental dysplasia, including signals in collagen-related genes and growth-factor pathways, with recent genome-wide studies uncovering nine distinct genetic loci associated with different subtypes of the condition.² But genes alone don’t explain everything. A family history of hip dysplasia, breech positioning in the womb, and traditional swaddling practices that hold the legs straight have all been identified as significant risk factors.³ This mix of inherited vulnerability and mechanical forces in the womb or early life means that the condition can range from a mildly shallow socket that stabilizes on its own to a fully dislocated hip that needs surgery.

The Challenge of Catching It Early

Early detection matters more than almost anything else for outcomes, and here the evidence is sobering. The classic bedside tests pediatricians use on newborns, where the examiner gently manipulates the hip to see if it clicks, slides, or resists movement, are highly specific but miss a lot of cases. A systematic review published in JAMA found that these clinical maneuvers had a sensitivity of only about 46%, meaning they caught fewer than half of affected hips.⁴ A separate meta-analysis reached a similar conclusion: clinical exams have high specificity but low sensitivity, making them unreliable as a standalone screening tool.⁵

This is why ultrasound screening matters. Countries differ in their approach: some offer ultrasound only when risk factors are present, while others screen every newborn. A cost-utility analysis modeled across the lifespan found that universal ultrasound at six weeks was the most cost-effective strategy compared with selective screening, at well under common willingness-to-pay thresholds.⁶ The debate isn’t settled, though. Other analyses have found that universal ultrasound’s higher upfront costs don’t always offset the reduction in late surgical cases.⁷ What everyone agrees on is that missing the diagnosis in infancy dramatically changes the treatment path.

Infant Treatment With the Pavlik Harness

When dysplasia is caught in the first few months of life, the Pavlik harness is the standard first-line treatment. It holds the baby’s legs in a flexed, outward position that nudges the ball of the hip deep into the socket, encouraging normal growth. For many families, this is where the story ends happily. Success depends on the severity of dysplasia, the baby’s age at the start of treatment, and whether one or both hips are affected.⁸

Recent work suggests that how the harness is monitored makes a real difference. A study comparing a standardized in-harness ultrasound protocol to routine follow-up found that the standardized approach raised the success rate from about 60% to 85% for dislocated hips, and dramatically fewer babies in the monitored group needed surgery afterward.⁹ That’s a big improvement just from checking positioning more carefully during treatment.

When the harness fails, though, the stakes go up. One study found that babies whose Pavlik harness treatment was unsuccessful had roughly four to five times the odds of developing avascular necrosis, a complication where the blood supply to the growing femoral head is disrupted, compared with babies who went straight to other treatments without a failed harness trial.¹⁰ This doesn’t mean the harness is dangerous. It means that prolonged use of a harness that isn’t working can do harm, and clinicians need to recognize failure quickly and change course. Separately, the length of time spent in the harness itself has been linked to avascular necrosis risk even in the healthy opposite hip, underscoring the importance of not overextending treatment duration.¹¹

When Babies and Young Children Need Surgery

If bracing fails or the diagnosis comes late, surgery enters the picture. For infants and toddlers, this typically means a closed reduction (putting the hip back in place without cutting) or an open reduction (a surgical procedure to physically place the ball into the socket and address any tissue blocking the way). A meta-analysis comparing the two approaches found that avascular necrosis rates were similar regardless of method, but closed reduction carried a significantly higher chance of needing a second surgery afterward, at about 30% versus 20% for open reduction.¹² Another study looking at radiographic outcomes at skeletal maturity found that hips treated with initial open reduction had better socket coverage measurements and again required fewer secondary procedures.¹³

For children with more severe cases, surgeons often combine open reduction with a pelvic osteotomy, a procedure that reshapes or redirects the socket to improve coverage. A large multicenter study of over 700 hips treated with open reduction for late-presenting dysplasia found an overall avascular necrosis rate of about 14%, with hips that also received a pelvic osteotomy showing a lower redislocation rate than those that did not.¹⁴ One series of patients who underwent a Salter innominate osteotomy found excellent or good clinical results in over 95% of cases, though follow-up periods varied.¹⁵ Triple pelvic osteotomy, a more extensive version of the same idea, effectively corrects residual acetabular dysplasia, though overcorrection in multiple planes is common and appears to have little clinical impact in young adults.¹⁶

Adults Who Discover They Have Hip Dysplasia

Not everyone is diagnosed in childhood. Some people coast through their teens and twenties with a mildly shallow socket and only start having hip pain in their thirties or forties. Others are athletes who develop groin pain that gets misattributed to a muscle strain for years before imaging reveals the underlying structural problem. Adult diagnosis relies on X-ray measurements such as the lateral center-edge angle, which quantifies how much the socket covers the femoral head, along with supplementary measures on specialized views.¹⁷ These measurements have been shown to be reliable across observers for most standard angles, giving clinicians a solid basis for treatment decisions.¹⁸

For adults with mild dysplasia and moderate symptoms, non-surgical management is a reasonable first step, though the evidence base remains thin. A clinical review noted that exercise and education are emerging as tools but that strong condition-specific evidence is still limited, and clinicians should focus broadly on quality of life and function rather than pain alone.¹⁹ Targeted hip abductor strengthening exercises have shown promise: one study found about a 16% improvement in abductor strength along with significant reductions in hip instability during walking and improved pain scores.²⁰ Exercise won’t change the shape of the socket, but it can compensate for instability and buy time.

Periacetabular Osteotomy in Adults

For younger adults with significant dysplasia but cartilage that’s still in decent shape, the periacetabular osteotomy (PAO) is the major joint-preservation option. The surgeon makes several cuts around the socket, rotates it into a better position over the femoral head, and fixes it in place. The goal is to normalize the joint mechanics and slow or stop cartilage breakdown. A meta-analysis found five-year hip survival (meaning the hip had not been converted to a replacement) of about 96%, dropping to roughly 91% at ten years and about 68% at twenty years.²¹ A separate systematic review estimated ten-year survivorship at about 76% and twenty-year survivorship closer to 37%, reflecting that outcomes vary across study populations.²² Both analyses agreed that the best results come from patients under 40 with minimal pre-existing arthritis.

The spread between those two meta-analyses is worth noticing. The difference likely reflects the severity mix in the underlying studies, the specific PAO technique used, and how strictly “failure” was defined. But either way, the pattern is clear: PAO buys a significant window of good hip function, and for many patients that window is measured in decades. Whether you consider that a “cure” or a “delay” depends on your expectations. A twenty-five-year-old who gets a PAO and doesn’t need a hip replacement until their sixties may well feel the condition was cured, practically speaking.

Hip Arthroscopy for Borderline Cases

Some adults have borderline dysplasia: a socket that’s a little shallow but not shallow enough to clearly warrant a PAO. These patients sometimes develop labral tears or cartilage damage at the rim of the socket because of the subtle instability. Hip arthroscopy, where the surgeon works through small incisions to repair the labrum and tighten the joint capsule, can help in selected cases. In one study of dysplastic hips treated arthroscopically with capsular tightening and labral repair, about 73% had good or excellent results, and the failure rate was around 18%.²³ The key here is patient selection: arthroscopy doesn’t fix the bony anatomy, so it works best when the structural deficiency is mild and the main problem is soft-tissue damage.

What Happens Without Treatment

One of the most common questions people with adult-diagnosed dysplasia ask is how fast things will get worse. The answer is: it varies, and often more slowly than you fear. A long-term observational study of adults with untreated dysplasia found that osteoarthritis developed in about 38% of dysplastic hips over an average follow-up of around eight years, but the rate wasn’t dramatically different from the comparison group of non-dysplastic hips from the same patients.²⁴ Another study looking at patients who hadn’t had surgery found an overall osteoarthritis rate of 20% and a hip-replacement rate of 11%.²⁵

That said, when arthritis does develop, it tends to move faster in dysplastic hips than in normal ones. Research tracking the natural history of hip degeneration found that among patients who had developed early arthritic changes, those with dysplasia had roughly a two-in-three chance of needing a hip replacement within twenty years, compared with about one in two for people with normal hip anatomy.²⁶ So dysplasia doesn’t guarantee arthritis, but it stacks the odds and accelerates the timeline once degeneration begins.

Total Hip Replacement as a Final Option

When cartilage is gone and joint-preservation surgery is no longer viable, total hip replacement remains an effective solution. Modern implants, both cemented and uncemented, offer promising results in dysplasia patients.²⁷ But the surgery is technically more demanding than a routine hip replacement. The socket may be small, shallow, or positioned abnormally. The thighbone is often distorted: it may be excessively angled or rotated. In severe cases where the hip has been dislocated since childhood, the surgeon may need to shorten the thighbone to bring it down to the level of the true socket.²⁸ Experienced surgeons with good preoperative planning can achieve excellent long-term function, but it’s worth seeking out a center that handles these cases regularly.

Getting Back to Sports and Normal Life

For younger, active patients who undergo a PAO, a major concern is whether they’ll be able to return to the activities they love. The evidence here is encouraging. A case series with five-year follow-up of patients with borderline dysplasia who had a PAO found a return-to-sports rate of over 92% among those who were active before surgery, with most resuming within six months. Activity scores improved significantly.²⁹ Another study of athletes who had PAO combined with hip arthroscopy found that about 86% returned to sport at some point, and of those, roughly 78% were still playing at the five-year mark, with high satisfaction scores across the board.³⁰ Recovery from PAO is not trivial—it’s a major bone surgery with months of limited weight-bearing—but for motivated patients, the long-term functional ceiling is high.

Emerging Therapies and Research Frontiers

The next wave of treatments aims to regenerate or preserve cartilage that’s already started to wear down. Biologic therapies, including platelet-rich plasma and stem-cell-based approaches, are being explored as ways to delay or reduce the need for joint replacement.³¹ None of these have reached the level of evidence needed to be considered standard care for dysplasia patients, but they represent a genuinely exciting direction. The gap in treatment has always been the intermediate stage: too much cartilage damage for a PAO to work well, but too young for a hip replacement to make sense. If biologic therapies can bridge that gap even partially, they’d change the treatment landscape.

On the surgical innovation front, patient-specific 3D-printed implants are being tested as a way to improve socket coverage without the extensive bone cuts of a traditional osteotomy. A proof-of-concept study using a canine model of naturally occurring hip dysplasia showed that custom shelf implants significantly improved femoral head coverage and joint stability.³² This is still preclinical work, and it’s a long way from being offered to patients. But it illustrates the direction the field is heading: toward more personalized, less invasive structural corrections. Dogs, it’s worth noting, develop hip dysplasia naturally and are one of the best animal models for studying it, with a treatment spectrum that mirrors the human one in many ways, from conservative management to total hip replacement.³³

Why “Cure” Is the Wrong Frame for Most Adults

For babies diagnosed early and treated with a harness, cure is the right word. The hip remodels, grows normally, and in many cases is indistinguishable from a hip that was never dysplastic. For children who need surgery, the picture is good but less clean: most achieve functional, pain-free hips, but some carry subtle anatomical differences and an elevated baseline risk for earlier arthritis. For adults, the honest framing is management rather than cure. A PAO reshapes the socket and can provide decades of function, but it doesn’t turn a dysplastic hip into a completely normal one. Exercise strengthens the muscles around the joint and reduces instability, but it doesn’t change the bone. Hip replacement eliminates the problem by eliminating the joint, which is an effective solution but not what most people mean by “cure.”

What matters more than the label is the trajectory. The evidence consistently shows that earlier intervention leads to better long-term function, fewer secondary procedures, and a longer lifespan for the native hip. A person diagnosed at any age has options that can substantially improve their quality of life, and for many the functional outcome is excellent. The question isn’t really whether dysplasia can be cured. It’s how much of the joint can be preserved, for how long, and at what level of activity. On those practical measures, modern treatment delivers well.